These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24916715)

  • 21. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
    Wu B; Shun N; Wei X; Wu W
    Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets.
    Krishnaiah YS; Satyanarayana V; Dinesh Kumar B; Karthikeyan RS; Bhaskar P
    Eur J Pharm Sci; 2003 Aug; 19(5):355-62. PubMed ID: 12907286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline.
    Mura P; Maestrelli F; Cirri M; González Rodríguez ML; Rabasco Alvarez AM
    J Drug Target; 2003 Jul; 11(6):365-71. PubMed ID: 14668057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro evaluation of khaya and albizia gums as compression coatings for drug targeting to the colon.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2005 Feb; 57(2):163-8. PubMed ID: 15720778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of a potential colonic drug delivery system of mesalamine.
    Gohel MC; Parikh RK; Nagori SA; Dabhi MR
    Pharm Dev Technol; 2008; 13(5):447-56. PubMed ID: 18798122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease.
    Sareen R; Jain N; Dhar KL
    Curr Drug Deliv; 2013 Oct; 10(5):564-71. PubMed ID: 23360241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colon specific delivery of indomethacin: effect of incorporating pH sensitive polymers in xanthan gum matrix bases.
    Asghar LF; Chure CB; Chandran S
    AAPS PharmSciTech; 2009; 10(2):418-29. PubMed ID: 19381832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theophylline colon specific tablets for chronotherapeutic treatment of nocturnal asthma.
    Yassin AE; Aodah AH; Al-Suwayeh S; Taha EI
    Pharm Dev Technol; 2012; 17(6):712-8. PubMed ID: 21486185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
    Cantor SL; Khan MA; Gupta A
    Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
    Bendas ER; Christensen JM; Ayres JW
    Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
    Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
    J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, development and optimization of oral colon targeted drug delivery system of azathioprine using biodegradable polymers.
    Nath B; Nath LK
    Pharm Dev Technol; 2013; 18(5):1131-9. PubMed ID: 23167303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eudragit S100 coated microsponges for Colon targeting of prednisolone.
    Kumari A; Jain A; Hurkat P; Tiwari A; Jain SK
    Drug Dev Ind Pharm; 2018 Jun; 44(6):902-913. PubMed ID: 29260916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.